Water pollution "caused by drugs" concern

11 May 2008

Trace amounts of pharmaceutical agents have been detected in the drinking water of several US cities, yet there is no federal policy for researching or dealing with the issue, according to a report by the Associated Press. In Philadelphia, 56 human and animal drug ingredients have been identified.

The Environmental Protection Agency's Assistant Administrator for Water, Benjamin Grumbles, told the AP that "our position is there needs to be more searching, more analysis."

However, the federal response is by no means united, with a spokesman from the Centers for Disease Control and Prevention (CDC) stating that the issue "is not a priority." The Food and Drug Administration, which can reject a marketing application for a drug on environmental grounds, "has never rejected one on this basis," the report said.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight